Opioid Use Disorder and COVID-19: Biological Plausibility for Worsened Outcomes.
Subst Use Misuse
; 55(11): 1900-1901, 2020.
Artículo
en Inglés
| MEDLINE | ID: covidwho-643514
ABSTRACT
BACKGROUND:
Alarms have been raised that COVID-19 may disproportionately affect certain populations with substance use disorders, particularly Opioid Use Disorder (OUD), however warnings have largely focused on social risks such as reduced availability of services.Objectives:
This commentary highlights three plausible biological mechanisms for potentially worsened outcomes in patients with OUD who contract COVID-19.Results:
Opioid-related respiratory depression may amplify risks of hypoxemia from COVID-19 viral pneumonia. Complex opioid immune modulation may impact host response to COVID-19, though the effect direction and clinical significance are unclear. Drug-drug interactions may affect individuals with OUD who are co-administered medications for OUD and medications for COVID-19, particularly due to cardiac adverse effects. Conclusions/Importance There are plausible biological mechanisms for potentially worsened outcomes in patients with OUD who contract COVID-19; these mechanisms require further study, and should be considered in individuals with OUD.Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Neumonía Viral
/
Arritmias Cardíacas
/
Insuficiencia Respiratoria
/
Huésped Inmunocomprometido
/
Infecciones por Coronavirus
/
Analgésicos Opioides
/
Trastornos Relacionados con Opioides
Tipo de estudio:
Estudio pronóstico
Tópicos:
Covid persistente
Límite:
Humanos
Idioma:
Inglés
Revista:
Subst Use Misuse
Asunto de la revista:
Trastornos Relacionados con Sustancias
Año:
2020
Tipo del documento:
Artículo
País de afiliación:
10826084.2020.1791184
Similares
MEDLINE
...
LILACS
LIS